Alaleh Nouri - 14 Sep 2021 Form 3/A - Amendment Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: EVP, CLO, CORP. SEC.
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
Issuer symbol: PRCT
Transactions as of: 14 Sep 2021
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 08 Dec 2023, 20:01:37 UTC
Date Of Original Report: 14 Sep 2021
Next filing: 04 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PRCT	Common Stock						43,064	14 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PRCT	Stock Option (Right to Buy)							14 Sep 2021	Common Stock	101,574	$4.52	Direct	F1, F2
holding	PRCT	Stock Option (Right to Buy)							14 Sep 2021	Common Stock	44,697	$4.56	Direct	F2, F3
holding	PRCT	Stock Option (Right to Buy)							14 Sep 2021	Common Stock	40,125	$5.18	Direct	F2, F4
holding	PRCT	Stock Option (Right to Buy)							14 Sep 2021	Common Stock	57,894	$7.27	Direct	F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock option was granted on September 28, 2018 and vests each monthly anniversary of July 9, 2018, the vesting commencement date, over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.
F2	The original Form 3 inadvertently reported a lower number of shares underlying each of the reported options, which have been corrected in this amended report. These incorrect share amounts were also reported in three Forms 4 filed by the reporting person after her original Form 3 was filed.
F3	The Stock option was granted on December 12, 2019 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.
F4	The Stock option was granted on August 10, 2020 and vests 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date.
F5	The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of June 22, 2021 and the remainder vests on each monthly anniversary over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.